Horizon Therapeutics Public Limited Company Net Income per Employee (HZNP), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Horizon Therapeutics Public Limited Company  (NASDAQ: HZNP)
 

Horizon Therapeutics Public Limited Net Income per Employee

HZNP's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 108.4% in the second quarter 2023, year on year to cumulative value of $438 million, and with 1,300 employees, Horizon Therapeutics Public Limited's income per employee grew on trailing twelve month basis to $ 336,925, this is below the company average income per employee.
The Healthcare sector has seen employees of 30 other companies achieving higher income per employee. While Horizon Therapeutics Public Limited's total ranking has deteriorated compared to the previous quarter from 110 to 386.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HZNP Net Income per Employee (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Net Income Change 108.4 % -73.23 % -30.47 % -58.4 % -61.44 %
Net Income per Employee (TTM) $ 336,925 286,081 401,140 441,735 588,431
HZNP's Total Ranking # 386 # 110 # 270 # 0 # 0
Seq. Net Income Change 132.37 % -54.58 % -11.36 % 122.78 % -70.15 %

HZNP Company Profile >> Back to HZNP Efficiency Comparisons >> Compare HZNP Net Income per Employee to its Competitors

HZNP Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 31
Healthcare Sector # 47
Overall Market # 386

Net Income per Employee Statistics
High Average Low
$ 663,156 $ 85,887 $ -411,834
(Mar 31 2022)   (Mar 31 2018)







Companies with similar Income per Employee for 12 month ending Jun 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2023Number of Employees Jun 30 2023
Siga Technologies Inc  580,307.39 $ 28.435  Million 49 
Ligand Pharmaceuticals Incorporated  577,829.79 $ 27.158  Million 47 
Semler Scientific inc   572,225.81 $ 17.739  Million 31 
Intercept Pharmaceuticals inc   556,349.33 $ 208.631  Million 375 
Halozyme Therapeutics Inc   552,494.09 $ 233.705  Million 423 
Avalo Therapeutics Inc   510,969.70 $ 16.862  Million 33 
Tenax Therapeutics Inc   498,652.25 $ 7.978  Million 16 
Regen Biopharma Inc   405,405.33 $ 1.216  Million 3 
Dynavax Technologies Corporation  401,301.82 $ 110.358  Million 275 
Maravai Lifesciences Holdings Inc   399,519.54 $ 173.791  Million 435 
Exicure Inc   383,125.00 $ 3.065  Million 8 
Biogen Inc   355,373.33 $ 2,665.300  Million 7,500 
Dariohealth Corp   346,715.15 $ 57.208  Million 165 
Horizon Therapeutics Public Limited Company  336,924.62 $ 438.002  Million 1,300 
Envoy Medical Inc   326,106.60 $ 3.261  Million 10 
Exelixis Inc   325,651.26 $ 373.522  Million 1,147 
Gilead Sciences Inc   320,176.47 $ 5,443.000  Million 17,000 
Tevogen Bio Holdings Inc   304,777.33 $ 5.486  Million 18 
Pfizer Inc  286,933.33 $ 21,520.000  Million 75,000 
Oramed Pharmaceuticals Inc  279,538.46 $ 3.634  Million 13 
Regeneron Pharmaceuticals Inc   278,974.69 $ 4,299.000  Million 15,410 
Revelation Biosciences Inc   259,189.22 $ 2.333  Million 9 
Moderna Inc   256,808.51 $ 1,207.000  Million 4,700 
Third Harmonic Bio Inc   252,075.47 $ 13.360  Million 53 
Bristol myers Squibb Company  245,446.15 $ 7,977.000  Million 32,500 
Omeros Corporation  230,182.86 $ 40.282  Million 175 
Entera Bio Ltd   206,681.82 $ 4.547  Million 22 
Aspire Biopharma Holdings Inc   177,591.58 $ 7.992  Million 45 


Date modified: 2026-09-12T06:14:33+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.